Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSXV/ROMJ stock hub

TSXV/ROMJ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/ROMJis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

33.8M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/ROMJ

In the news

Latest news · TSXV/ROMJ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.3

P25 11P50 15.6P75 25.4

Trailing P/E31.4

P25 7.4P50 15.6P75 34.3

ROE2.6

P25 -121.5P50 -40.9P75 0.5

ROIC2.2

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/ROMJ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

CAD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	266
Employees Change	56%
Employees Change Percent	26.67
Enterprise value	CAD 40.6M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA78112W1005
Last refreshed	2026-05-10
Market cap	CAD 33.8M
Price	CAD 0.5
Price currency	CAD
Rev Per Employee	224,339.62x
Sector	Healthcare
Sic	2834
Symbol	tsxv/ROMJ
Website	https://www.rubiconorganics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.11%
EV Earnings	38.66x
EV/EBIT	22.26x
EV/EBITDA	8.39x
EV/FCF	-3.55x
EV/Sales	0.68x
FCF yield	-33.9%
Forward P/E	13.26x
P/B ratio	0.77x
P/E ratio	31.36x
P/S ratio	0.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.07%
EBITDA Margin	8.04%
Gross margin	37.24%
Gross Profit	CAD 22.1M
Gross Profit Growth	43.56%
Gross Profit Growth Q	-22.2%
Gross Profit Growth3 Y	17.04%
Net Income	CAD 1.1M
Net Income Growth Years	1%
Pretax Margin	1.77%
Profit Margin	1.77%
Profit Per Employee	CAD 3,966
Profitable Years	1
ROA	1.85
Roa5y	-3.87
ROCE	3.34
ROE	2.58
Roe5y	-12.37
ROIC	2.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	11.12%
Cagr3y	-3.13%
Cagr5y	-30.03%
EPS Growth Years	1
Revenue Growth	22.08x
Revenue Growth Q	15.92x
Revenue Growth Quarters	8x
Revenue Growth Years	5x
Revenue Growth3 Y	18.73x
Revenue Growth5 Y	44.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.96
Assets	CAD 66.9M
Cash	CAD 5.6M
Current Assets	CAD 35.8M
Current Liabilities	CAD 12.2M
Debt	CAD 12.4M
Debt EBITDA	CAD 2.56
Debt Equity	CAD 0.28
Debt FCF	CAD -1.08
Equity	CAD 44.1M
Interest Coverage	2.58
Liabilities	CAD 22.8M
Long Term Assets	CAD 31.1M
Long Term Liabilities	CAD 10.7M
Net Cash	CAD -6.8M
Net Cash By Market Cap	CAD -20.25
Net Debt EBITDA	CAD 1.43
Net Debt Equity	CAD 0.16
Tangible Book Value	CAD 41.7M
Tangible Book Value Per Share	CAD 0.62
WACC	5.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.94
Inventory Turnover	2.33
Net Working Capital	CAD 19.8M
Quick ratio	1.22
Working Capital	CAD 23.6M
Working Capital Turnover	CAD 2.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	11.11%
200-day SMA	0.51
3Y total return	-9.09%
50-day SMA	0.51
50-day SMA vs 200-day SMA	50under200
5Y total return	-83.22%
All Time High	5.25
All Time High Change	-90.48%
All Time High Date	2018-10-10
All Time Low	0.3
All Time Low Change	69.49%
All Time Low Date	2024-11-21
ATR	0.02
Beta	0.38
Beta1y	1.17
Beta2y	-0.03
Ch YTD	5.26
High	0.51
High52	0.73
High52 Date	2025-09-02
High52ch	-31.51%
Low	0.5
Low52	0.39
Low52 Date	2025-05-28
Low52ch	29.87%
Ma50ch	-1.83%
Price vs 200-day SMA	-2.5%
RSI	45.3
RSI Monthly	47.99
RSI Weekly	50
Sharpe ratio	0.31x
Sortino ratio	0.59
Total Return	-14.38%
Tr YTD	5.26
Tr1w	-1.96%
Tr3m	13.64%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 1.8M
Operating margin	3.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,007,522%
Net Borrowing	2,163,000
Shares Insiders	42.28%
Shares Institutions	4.21%
Shares Out	67,578,916
Shares Qo Q	-0.9%
Shares Yo Y	14.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -12.9M
Average Volume	61,581.95x
Bv Per Share	0.66
CAPEX	CAD -8.4M
Ch1w	-1.96
Ch1y	11.11
Ch3m	13.64
Ch3y	-9.09
Ch5y	-83.22
Ch6m	2.04
Change	0%
Change From Open	-1.96
Close	0.5
Days Gap	2
Depreciation Amortization	2,957,000
Dollar Volume	6,100
Earnings Date	2026-05-13
EBIT	CAD 1.8M
EBITDA	CAD 4.8M
EPS	CAD 0.02
F Score	5
FCF	CAD -11.5M
FCF EV Yield	-28.19x
FCF Per Share	CAD -0.17
Financing CF	5,667,000
Fiscal Year End	December
Founded	2,015
Graham Number	0.48507
Graham Upside	-2.99
Investing CF	-8,416,000
Is Primary Listing	1
Last Earnings Date	2026-03-23
Last Report Date	2025-12-31
Ma150	0.5
Ma150ch	0.87%
Ma20	0.53
Ma20ch	-5.98%
Net CF	-5,868,000
Next Earnings Date	2026-05-13
Open	0.51
Position In Range	0
Ppne	28,682,000
Price Date	2026-05-08
Price EBITDA	CAD 7.07
Ptbv Ratio	0.81
Relative Volume	0.2x
Revenue	59,450,000x
SBC By Revenue	2.43x
Share Based Comp	1,443,000
Tr6m	2.04%
Volume	12,200
Z Score	0.26

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/ROMJ pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/ROMJ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/ROMJ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.2%

Share of float held by funds and institutions

Insider ownership

+42.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+14.4%

Negative means the company is buying back shares.

Technical

TSXV/ROMJ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.3

Neutral momentum band

Price vs 200-day MA

-2.5%

50/200-day relationship not available

Beta (5Y)

0.38

Less volatile than the market

Sharpe ratio

0.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/ROMJ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/ROMJ stock rating?

tsxv/ROMJ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/ROMJ analysis?

The full report lives at /stocks/tsxv/ROMJ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/ROMJ?

The latest report frames tsxv/ROMJ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/ROMJ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.